SOW
ACRS icon

State of Wyoming’s Aclaris Therapeutics ACRS Stock Holding History

State of Wyoming’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Buy
+27,439
New +$122K 0.01% 1209
2025
Q2 		– Sell
-46,861
Closed -$71.7K – 1836
2025
Q1 		$71.7K Buy
+46,861
New +$100K 0.01% 1314
2023
Q1 		– Sell
-5,533
Closed -$87.1K – 1572
2022
Q4 		$87.1K Buy
+5,533
New +$89K 0.03% 841

Other funds holding ACRS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

State of Wyoming's ACRS Position: Q2 2026 in Review

State of Wyoming opened a new position in Aclaris Therapeutics (ACRS) in Q2 2026: 27,439 shares worth $145K. The stake represents 0.01% of the portfolio and ranks #1209 among its holdings. This is a return to the name: State of Wyoming previously reported a position in ACRS as recently as Q1 2025.

State of Wyoming first reported a position in ACRS in Q4 2022 and has held it in 3 quarters since. 148 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

  • State of Wyoming held 27,439 shares of Aclaris Therapeutics worth $145K as of Q2 2026.
  • Aclaris Therapeutics was a new State of Wyoming position in Q2 2026.
  • Aclaris Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1209 holding.
  • State of Wyoming first reported a position in Aclaris Therapeutics in Q4 2022 and has held it in 3 quarters since.
  • 148 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.